Try our Advanced Search for more refined results
Appellate
Appellate Law360 provides breaking news and analysis on appellate law. Coverage includes major cases in the federal courts of appeal, the U.S. Supreme Court, and state-level appeals courts, with a focus on petitions, briefs, oral arguments, decisions, and other major activity.
Sign up for a 7-day FREE trial today!
Latest News in Appellate
-
December 23, 2025
Top Illinois Decisions Of 2025
State and federal courts have handed down rulings in Illinois cases this year that made clear plaintiffs must allege concrete injury for common law standing, narrowed the scope of the federal anti-kickback statute and laid out a new standard for certifying collective actions.
-
December 23, 2025
Intent Not Needed To Boost ID Theft Sentence, 9th Circ. Says
Federal prosecutors need not show that a defendant intended to commit fraud with stolen materials that have authentication features, such as driver's licenses, for courts to apply a sentencing enhancement for possessing those materials, the Ninth Circuit has held.
-
December 23, 2025
3 Federal Circuit Clashes To Watch In January
The Federal Circuit is set to hear several intellectual property cases in January, including one over a nine-figure patent judgment against cybersecurity company Gen Digital tied to a contempt finding against a major law firm that represented it, and another over the tech industry's long-running crusade against patent review denials based on related litigation.
-
December 23, 2025
Full 9th Circ. Won't Hear Ex-Theranos Exec Balwani's Appeal
A Ninth Circuit panel rejected ex-Theranos executive Ramesh "Sunny" Balwani's en banc hearing request to reconsider his 12-count conviction and nearly 13-year prison sentence, while also amending its opinion to clarify that there was "ample evidence" to convict Balwani, even if prosecutors failed to correct a witness's testimony.
-
December 23, 2025
Justices Urged To Spurn SG's Call To Tackle 'Skinny Labels'
Amarin Pharma Inc. on Tuesday urged the U.S. Supreme Court to reject the U.S. solicitor general's call to hear a patent case involving generic drug "skinny labels," saying the dispute over the company's heart drug Vascepa deals with factual issues not suitable for high court review.
Areas of Coverage
- LITIGATION
- Petitions and notices of appeal in federal and state appeals courts
- Appellant and opposition briefs
- Solicitor general briefs
- Oral arguments in appellate cases
- Opinions handed down by appellate judges and panels
- Bankruptcy appeals
- POLICY & REGULATION
- Federal and state regulation and legislation that affects appellate procedure
- Legislative responses to or attempts to overturn appeals court decisions
- PROFILES
- Nominations and appointments of appellate judges and justices
- Personnel moves
Readership
- Appellate lawyers at top law firms
- Judges and court staff across the U.S.
- Policymakers at federal and state agencies
- Corporate counsel and compliance officers at Fortune 1000 companies
- Information experts at law firms, agencies, and companies
- Professors, students, and library staff at every accredited law school in the U.S.
- Attorney and law firm marketing professionals